Early Warning Report



    MONTREAL, April 27 /CNW Telbec/ - In accordance with regulatory
requirements, Richard Groome announces that he has recently sold 7,760,000
common shares of Mistral Pharma Inc. ("Mistral"), a TSX Venture Exchange
company (MIP) which he owned, directly or indirectly, or had control over. As
a result of this disposition, Mr. Groome still holds or exercises control or
direction over an aggregate of 6,740,000 common shares of Mistral which
represents an interest of 4.06% in Mistral's issued and outstanding capital at
the date hereof on a non-diluted basis. Mr. Groome's ownership in Mistral has
therefore decreased by 4.67% since his previously reported percentage of 8.72%
in June 2006. Assuming the exercise of all warrants still held by Notre-Dame
Capital, a corporation controlled by Mr. Groome, he will hold or exercise
control or direction over an aggregate of 15,885,300 common shares of Mistral,
which represents an interest of 9.06% of Mistral's issued and outstanding
capital at the date hereof on a non-diluted basis.
    The securities sold by Mr. Groome were for cash proceeds. This investment
will be reviewed on a continuing basis and holdings may be increased or
decreased in the future, depending on economic or market conditions or matters
relating to the applicable issuer.

    The TSX Venture Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this press release nor
    have they approved nor disapproved the content thereof.




For further information:

For further information: or to obtain a copy of the early warning
report, communicate with: Ms. Sarah Perry, Notre-Dame Capital Inc., (514)
907-4989

Organization Profile

MISTRAL PHARMA INC.

More on this organization

NOTRE-DAME CAPITAL INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890